Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
The American Review of Respiratory Disease
|
October 1, 1988
Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. II. Two-month, daily administration study
G Acocella, A Nonis, G Perna, et al.
Giornale Italiano Di Chemioterapia
|
January 1, 1989
Eskimo: an epidemiological simulation kinetic model for tuberculosis
G Acocella, W Pollini, L Pelati, et al.
Pharmacological Research Communications
|
July 1, 1984
Pharmacokinetic study on intravenous rifampicin in man
G Acocella, G Segre, R Conti, et al.
Gut
|
January 1, 1972
Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease
G Acocella, L Bonollo, M Garimoldi, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|
October 1, 1992
Tuberculosis and HIV infection association in a rural district of northern Uganda: epidemiological and clinical considerations
G B Migliori, A Borghesi, C Adriko, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|
June 1, 1992
Proposal of an improved score method for the diagnosis of pulmonary tuberculosis in childhood in developing countries
G B Migliori, A Borghesi, P Rossanigo, et al.
The Journal of Antimicrobial Chemotherapy
|
March 1, 1989
Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study
G Acocella, A Bertrand, J Beytout, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
The American Review of Respiratory Disease
|
October 1, 1988
Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. II. Two-month, daily administration study
G Acocella, A Nonis, G Perna, et al.
Giornale Italiano Di Chemioterapia
|
January 1, 1989
Eskimo: an epidemiological simulation kinetic model for tuberculosis
G Acocella, W Pollini, L Pelati, et al.
Pharmacological Research Communications
|
July 1, 1984
Pharmacokinetic study on intravenous rifampicin in man
G Acocella, G Segre, R Conti, et al.
Gut
|
January 1, 1972
Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease
G Acocella, L Bonollo, M Garimoldi, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|
October 1, 1992
Tuberculosis and HIV infection association in a rural district of northern Uganda: epidemiological and clinical considerations
G B Migliori, A Borghesi, C Adriko, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|
June 1, 1992
Proposal of an improved score method for the diagnosis of pulmonary tuberculosis in childhood in developing countries
G B Migliori, A Borghesi, P Rossanigo, et al.
The Journal of Antimicrobial Chemotherapy
|
March 1, 1989
Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study
G Acocella, A Bertrand, J Beytout, et al.
Page
of 5